Výsledky vyhledávání - "Galit Perets"

Akademický článek

Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of Patients with Hematologic Malignancies Using Busulfan, Fludarabine, and Total Body Irradiation Conditioning Is Effective in an Elderly and Infirm Population

Autor: Brammer, Jonathan E., Stentz, Alexander, Gajewski, James, Curtin, Peter, Hayes-Lattin, Brandon, Kovacsovics, Tibor, Leis, Jose F., Meyers, Gabrielle, Nemecek, Eneida, Subbiah, Nan, Frires, Rachel, Palmbach, Gundula, Avraham, Galit Perets, Slater, Susan, Maziarz, Richard T.

Publikováno v: In Biology of Blood and Marrow Transplantation January 2015 21(1):89-96

Zobrazit plný text záznamu

Allogeneic Stem Cell Transplantation in Treatment Related and Secondary Acute Myeloid Leukemia and Myelodysplastic Syndrome: Ohsu Experience

Autor: Galit Perets, Rachel J. Cook, Staci Williamson, Charles Dibb, Jessie Myers, Gabrielle Meyers, Richard T. Maziarz, Luke B Fletcher, Curtis Lachowiez

Publikováno v: Transplantation and Cellular Therapy. 27:S159-S161

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1b21396fd5d6a92ecc1b0dca82196581
https://doi.org/10.1016/s2666-6367(21)00197-4

Zobrazit plný text záznamu

Venetoclax Is Safe and Efficacious in Relapsed/ Refractory AML

Autor: Alexander Gural, Ronit Yerushalmi, Jacob M. Rowe, Maya Koren-Michowitz, Oren Pasvolsky, Vladimir Vainstein, Shay Yeganeh, Chezi Ganzel, Boaz Nachmias, Miri Zektzer, Yakir Moshe, Sharon Gino-Moor, Yishai Ofran, Arie Apel, Yoseph Cohen, Ron Ram, Ofir Wolach, Ivetta Danylesko, Galit Perets

Publikováno v: Blood. 134:5091-5091

Introduction: On November 2018 the FDA approved the treatment of venetoclax together with hypomethylating agent (HMA) or low dose cytarabine (LDAC) for newly diagnosed AML patients who cannot tolerate intensive chemotherapy. There is limited data reg

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6f6b82fcfc0e0282da065ab1f14352da
https://doi.org/10.1182/blood-2019-125662

Zobrazit plný text záznamu

Venetoclax and DLI for Patients with Early Relapse of Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation. a Historical Prospective Multicenter Trial

Autor: Bruria Yachini, Galit Perets, Odelia Amit, Lena Atlas, Liat Shargian, Ron Ram, Moshe Yeshurun, Chen Karni, Yael Bar-On

Publikováno v: Blood. 134:2018-2018

Introduction: Prognosis in patients with post allogeneic HCT-early relapse of AML is dismal and response to salvage treatment is less than 20%. Venetoclax has been shown to be safe and efficacious in frail/elderly patients with AML. Treatment results

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a84d3c4280eeec13afed0de229cee426
https://doi.org/10.1182/blood-2019-126999

Zobrazit plný text záznamu

Is the Achievement of Pre-Autologous Transplant CR Necessary Indeed in Refractory/ Relapsed DLBCL Patients? a Retrospective Multicenter Study

Autor: Liat Shargian-Alon, Chava Perry, Moshe Yeshurun, Ron Ram, Galit Perets, Irit Avivi, Pia Raanani, Oren Pasvolsky, Michal Navon Sela, Ronit Gurion, Odelia Amit, Hanna Bernstine, Anat Gafter-Gvili

Publikováno v: Blood. 134:5703-5703

Introduction - Salvage chemotherapy followed by autologous hematopoietic cell transplantation (auto-HCT) is the standard-of-care for relapsed and refractory (R/R) diffuse large B cell lymphoma (DLBCL) patients. Eligibility is based on the presence of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f8e43233b3362d61bf85080ead97ff8a
https://doi.org/10.1182/blood-2019-131229

Zobrazit plný text záznamu

Radiation-Free Protocol for Patients with Acute Lymphoblastic Leukemia and Mixed Phenotype Acute Leukemia Undergoing Induction Chemotherapy and Allogeneic Hematopoietic Cell Transplantation - a Multicenter Historical Prospective Study

Autor: Irit Avivi, Ron Ram, Itai Levi, Galit Perets, Odelia Amit, Tsila Zuckerman, Israel Henig, Yael Bar-On, Shimrit Ringelstein Harlev, Dana Yehudai-Ofir

Publikováno v: Blood. 134:5654-5654

Introduction: Acute lymphoblastic leukemia (ALL) and mixed phenotype acute leukemia (MPAL) in adults are associated with a cure rate of only 20 and with a tendency for relapse to the CNS. Total body irradiation (TBI)-based high dose therapy and allog

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::34db45dae1c8f0d2af6369a921728aa8
https://doi.org/10.1182/blood-2019-128248

Zobrazit plný text záznamu

Nonmyeloablative allogeneic hematopoietic stem cell transplant for the treatment of patients with hematologic malignancies using busulfan, fludarabine, and total body irradiation conditioning is effective in an elderly and infirm population

Autor: Alexander Stentz, Jonathan E. Brammer, N. Subbiah, Gabrielle Meyers, Jose F. Leis, Rachel Frires, James Gajewski, Eneida R. Nemecek, Susan Slater, Peter T. Curtin, Galit Perets Avraham, Tibor Kovacsovics, Gundula Palmbach, Richard T. Maziarz, Brandon Hayes-Lattin

Publikováno v: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(1)

The BuFluTBI conditioning regimen was designed with the primary goal of reducing non-relapse mortality (NRM) while maximizing primary disease control in patients ineligible for myeloablative conditioning. Patients with hematologic malignancies for wh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c5f5de8a9216a189d9bc500e11ed77f
https://pubmed.ncbi.nlm.nih.gov/25445641

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání